BACKGROUND Allergic bronchopulmonary aspergillosis occurs in 7-10% of cystic fibrosis (CF) and 1-2% of asthmatic patients. HLA-DR restriction and increased sensitivity to IL-4 stimulation have been proposed as risk factors in these populations. OBJECTIVE We examined for the presence of IL-4 receptor alpha chain (IL-4Ralpha) single nucleotide polymorphisms (SNPs) in ABPA and whether these acco...

The amylase-binding protein A (AbpA) of Streptococcus gordonii was found to be undetectable in supernatants of mid-log-phase cultures containing >1% glucose but abundant in supernatants of cultures made with brain heart infusion (BHI), which contains 0.2% glucose. A 10-fold decrease in the level of abpA mRNA in S. gordonii cells cultured in BHI was noted after the addition of glucose to 1%. Ana...

BACKGROUND IgG and IgG subclass antibodies to Aspergillus fumigatus (A fumigatus) were measured in a large population of patients with cystic fibrosis to elucidate a putative antibody pattern specific for allergic bronchopulmonary aspergillosis (ABPA). METHODS An ELISA technique using water soluble somatic hyphal (WSSH) A fumigatus antigens and subclass specific monoclonal antibodies was used...

Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by asthma, peripheral eosinophilia, pulmonary infiltrates, hypersensitivity to Aspergillus fumigatus and bronchiectasis. The treatment of ABPA depends on the stage of the disease, and includes following clinical symptoms, serum IgE levels, pulmonary function tests, and chest radiographs. This review covers the current tre...

BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA), which is predominantly a disease of asthmatic subjects, is caused by hypersensitivity to Aspergillus antigens. Screening for Aspergillus sensitization in asthmatic subjects could identify those who are at risk for ABPA. Few studies have shown that fungal sensitization could be an important risk factor for asthma severity. We sought to d...

Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction in patients with asthma or cystic fibrosis (CF), which is associated with bronchi colonized by the fungus Aspergillus species, most often Aspergillus fumigatus. ABPA is an important consideration for asthmatics that do not respond to asthma management or with recurrent chest infections and deteriorating lung f...

La aspergilosis broncopulmonar alérgica (ABPA) es una enfermedad inflamatoria de las vías respiratorias, origen inmunitario, que afecta principalmente a pacientes con fibrosis quística (FQ) y, menor frecuencia, asma. ABPA puede causar lesiones pulmonares irreversibles y bronquiectasias si no se trata forma temprana activa. Los esteroides orales largo plazo, el tratamiento estándar para la ABPA,...

Allergic bronchopulmonary aspergillosis (ABPA), an asthmatic disease, is caused primarily by hypersensitivity to Aspergillus species. ABPA is rarely observed in the absence of asthma, which is, in fact, the principle criterion for its diagnosis. Here, we report the case of a 36-yr-old woman without a history of bronchial asthma, who manifested a localized pneumonic consolidation, coupled with b...

Allergic bronchopulmonary aspergillosis (ABPA) is the result of hypersensitivity to Aspergillus antigens in patients with long-standing atopic asthma. In the present study mycelial and culture filtrate antigens from Aspergillus fumigatus cultures isolated from diverse sources were tested against sera of 10 ABPA patients and 10 control individuals by an ELISA methodology. The results indicate hi...

1. Abstract 2. Introduction 3. MHC Class I and II Molecules 3.1. Function of MHC Class I and Class II molecules 3.2. Structure of MHC Class I and Class II molecules 3.3. Antigen binding by MHC Class I and Class II molecules 3.4. MHC polymorphism on peptide binding 3.5. Antigen presentation by MHC Class II molecules 4. MHC and disease associations 4.1. Associations between MHC polymorphism and d...